CRISPR

The FDA recently decided that simple CRISPR-induced changes in plants did not represent genetic modification. Then why do those officials feel differently about the same CRISPR-induced changes in animals? 
CRISPR-Cas9, unlike other methods, can create food products so close to the original that they are not considered genetically-modified organisms. That's because it's not how the process of change is of regulatory concern, but instead, it's the final result. Biosimilar is not genetically modified. 
Last year, a paper about CRISPR's potential off-target mutations that called CRISPR's safety into question received a lot of attention. The CRISPR field swiftly became defensive and publicly questioned the research. Turns out that authors of the paper also saw the flaws because they have recently published a "do-over" paper that discounts the original findings.   
Wheat is one of our most important crops. Unlike corn and soy, GMO versions are not sold. There are several reasons for that, but one is the complexity of the wheat genome and challenges of altering it. Now, CRISPR-Cas9 gene editing may have created a bigger, better wheat. 
Over the last decade, the gene-editing technology CRISPR – Clustered Regularly Interspaced Short Palidromic Repeats – has nearly become a household word. Now, there's a new publication dedicated to the process. It's a peer-reviewed journal and its inaugural issue just came out.
Human genome editing, like self-driving cars or drone delivery, may become part of our everyday lives faster than we realize it. A panel discussion entitled "The Future of Gene Editing" brought together four experts to tackle the challenges, as they apply to humans, from different approaches and perspectives.
The controversy over GMOs lives on, despite the scientific community's best efforts to quell the scaremongering. In order to gather the public's concerns, the FDA is requesting comments on the topic of genome editing, in the production of plants that would be eaten by both humans and animals.
Some scientific discoveries, like human genome editing, challenge our thinking on many levels. And there are many voices getting into the mix of the debate on this subject, taking on the unenviable task of "playing God."